Sign in

You're signed outSign in or to get full access.

Lawrence D. Kingsley

Director at Mirion TechnologiesMirion Technologies
Board

About Lawrence D. Kingsley

Independent director at Mirion Technologies (MIR) since October 2021 (tenure ~3.5 years), age 62. Kingsley brings deep operating and board leadership experience as former CEO/President of IDEX Corporation and Chairman/CEO of Pall Corporation through its 2015 sale to Danaher. He holds a B.S. in Industrial Engineering & Management from Clarkson University and an MBA from the College of William & Mary .

Past Roles

OrganizationRoleTenureCommittees/Impact
Pall CorporationPresident & CEO; ChairmanOct 2011–Aug 2015 (CEO/President); Oct 2013–Aug 2015 (Chair)Company acquired by Danaher in Aug 2015
IDEX CorporationCEO & President; COOMar 2005–Aug 2011 (CEO/President); Aug 2004–Mar 2005 (COO)Public company operating/strategy leadership
Danaher CorporationCorp. VP & Group Executive; President, Industrial Controls; President, Motion GroupJan 2001–Aug 2004Progressive operating leadership roles
Rockwell Automation, Inc.Director (public)2013–2021Board service at global industrial automation leader
Cooper Industries plcDirector (public)2007–2012Board service
IDEX CorporationDirector (public)2005–2011Board service alongside executive roles
Kollmorgen; WeidmullerManagement rolesNot disclosedIncreasing responsibility in industrial firms

External Roles

OrganizationRoleTenureNotes
IDEXX Laboratories, Inc. (public)Independent Non‑Executive Board ChairSince Nov 2019Chair of leading veterinary diagnostics company
Polaris Industries Inc. (public)DirectorSince Jan 2016Board member at powersports manufacturer
Berkshire Partners LLC (private)Advisory DirectorSince May 2016Advisory role at investment firm
Consolidated Precision Products (private)DirectorSince Sep 2019Board member
Harvey Performance Company (private)DirectorSince Sep 2023Board member

Board Governance

  • Committee assignments: Compensation Committee (member); Nominating & Corporate Governance Committee (member). Not a member of Audit. Chairs are Robert A. Cascella (Compensation) and John W. Kuo (Nominating & Governance) .
  • Independence: Board determined Kingsley is independent under NYSE and SEC rules; seven of eight directors are independent .
  • Attendance and engagement: Board met 7 times in 2024; each director attended at least 75% of Board and committee meetings. Independent director executive sessions are held at the end of regularly scheduled Board meetings .
  • Board leadership: CEO Thomas D. Logan is Chair; Kenneth C. Bockhorst is Lead Independent Director .
  • Governance practices: Prohibition on hedging/pledging by directors; as of the record date there were no outstanding pledges by any officers or directors .
Governance ItemDetail
CommitteesCompensation (member); Nominating & Governance (member)
IndependenceIndependent director
2024 Attendance≥75% of Board/committee meetings (all directors)
Executive SessionsIndependent director sessions each regular meeting
Lead Independent DirectorKenneth C. Bockhorst (not Kingsley)
Hedging/PledgingProhibited; no pledges outstanding at record date

Fixed Compensation

2024 Director Fees – KingsleyAmount (USD)
Fees earned or paid in cash$76,500
Stock awards (RSUs, grant date fair value)$140,000
Total$216,500
Form of fee receiptElected to receive Q1 & Q2 2024 fees in fully vested Class A shares; remainder in cash
Director Compensation Program (updated 6/4/2024)Annual Cash Retainer
Board Service$76,500
Lead Independent Director (add-on)$30,000
Audit Committee Chair (add-on)$20,000
Compensation Committee Chair (add-on)$15,000
Nominating/Governance Committee Chair (add-on)$12,500

Performance Compensation

  • Equity mix and vesting: Non-employee directors receive annual RSU grants. For 2024 grants made before June 4, 2024, the target value was ~$93,500; effective June 4, 2024 and thereafter, annual RSU value is $140,000. RSUs vest quarterly and are fully vested on the earlier of the first anniversary of grant or the next annual meeting, subject to continued service. No options or performance-vesting conditions are used for directors .
Director Equity DetailValue/Units
2024 annual RSU grant policy$140,000 (effective 6/4/2024; prior 2024 grants ~$93,500)
Kingsley 2024 stock awards (grant-date fair value)$140,000
RSUs outstanding at 12/31/2024 (Kingsley)6,750 units
RSUs expected to vest/settle within 60 days of 3/17/2025 (Kingsley)3,375 shares

Other Directorships & Interlocks

CompanyTypeRolePotential Interlock/Conflict
IDEXX Laboratories, Inc.PublicIndependent Non‑Executive Board ChairNo MIR-related transactions disclosed
Polaris Industries Inc.PublicDirectorNo MIR-related transactions disclosed
Consolidated Precision Products; Harvey PerformancePrivateDirectorNo MIR-related transactions disclosed
Berkshire Partners LLCPrivateAdvisory DirectorNo MIR-related transactions disclosed
  • Related-party/legacy SPAC interests: As part of the SPAC business combination, Kingsley held “Profits Interests” that performance-vested at MIR share price thresholds ($12/$14) and were fully settled into Class A shares by year-end 2024; no ongoing warrants remain at the sponsor after the June 4, 2024 warrant exchange .

Expertise & Qualifications

  • Executive leadership and operations: Former CEO/President (IDEX), Chairman/CEO (Pall) with extensive strategic planning, corporate development and operations analysis experience .
  • Capital markets/M&A and public company governance: Multiple public board roles, including current Chair of IDEXX and director of Polaris; prior board service at Rockwell Automation, Cooper Industries, IDEX and Pall .
  • Education: B.S. Industrial Engineering & Management (Clarkson); MBA (William & Mary) .

Equity Ownership

CategoryAmount
Total beneficial ownership – Class A shares4,749,935 (2.1% of Class A outstanding)
Held directly by Kingsley46,560 shares
Lawrence D. Kingsley Revocable Trust4,200,000 shares
Diane Kingsley Revocable Trust350,000 shares
Lawrence D. Kingsley 2015 Family Irrevocable Trust150,000 shares
RSUs outstanding at 12/31/20246,750 units
RSUs expected to vest/settle within 60 days of 3/17/20253,375 shares
Ownership guidelines for directors5x annual cash retainer; includes shares, unvested RSUs/DSUs; must retain net shares until compliant; all participants currently in compliance
Hedging/Pledging statusHedging and pledging prohibited; no pledges outstanding at record date

Governance Assessment

  • Positives:
    • Independent director with deep operating experience in relevant industrial/health tech adjacencies; significant public-company board leadership (Chair of IDEXX) .
    • Strong ownership alignment: ~2.1% of Class A via direct and trust holdings; elected to take part of 2024 director fees in stock; subject to and compliant with 5x retainer stock ownership guideline; no pledging allowed or outstanding .
    • Active committee service (Compensation; Nominating & Governance); board met 7x in 2024 with at least 75% attendance for all directors; independent director executive sessions in each regular meeting .
    • Director compensation structure emphasizes equity (annual RSUs with regular vesting), and governance policies include a prohibition on hedging/pledging and robust related-party review by the Audit Committee .
    • Broader governance climate: 2024 Say‑on‑Pay support ~93%, and Compensation Committee advisor independence assessed with no conflicts found .
  • Watch items:
    • Multiple outside board and advisory roles (IDEXX chair; Polaris director; private company boards) increase time commitments, though no attendance issues were disclosed and each director met ≥75% threshold in 2024 .
    • Legacy SPAC‑related “Profits Interests” were fully settled into Class A shares by 12/31/2024; not an ongoing related‑party arrangement but noteworthy in assessing historical incentives .
  • No red flags disclosed: No related‑party transactions with entities where Kingsley serves; no hedging/pledging; no Section 16(a) delinquency disclosed for Kingsley (company noted late filings for two other directors, not Kingsley) .